IL2 and neoplasm: Also, Pieper et al., studying responses of an irradiated tumor and associated lung micrometastases in a head and neck cancer model, found a superior antitumor effect of RT/pegylated IL-2/anti-PD-L1 triple treatment and better survival compared to RT/anti-PD-L1 but not RT/pegylated IL-230.